Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sperm flagellar protein 2 (SPEF2) is a structural and functional protein required for the assembly and integrity of the axoneme—the core cytoskeletal structure of sperm flagella and motile cilia[1][3]. It is essential for normal sperm motility and morphology, acting as a component of the central pair complex and interacting with proteins involved in intra-flagellar transport (IFT), such as IFT20, and axonemal radial spoke proteins like RSPH9[1][2]. SPEF2 is broadly expressed in ciliated tissues (testis, lung, brain, trachea, spleen) and has additional roles in osteoblast differentiation and bone formation, implicated via cilia-related signaling and protein transport[2]. Loss-of-function mutations cause severe male infertility (MMAF), primary ciliary dyskinesia, and skeletal abnormalities, but currently, there are no approved drugs targeting SPEF2 nor is it considered a therapeutic target. SPEF2's primary importance is as a structural protein and a genetic factor in the pathogenesis of certain ciliopathies and infertility syndromes, making it a valuable biomarker but not a classic druggable target[1][2][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sperm flagellar protein 2 (SPEF2).